A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men

Summary

Fibrinogen, a major determinant of blood viscosity, is an acute phase protein associated with cardiovascular disease. We studied the association of hypertension with single nucleotide polymorphisms (SNPs) in the gene encoding the fibrinogen β chain (FGB). Three tagging SNPs (rs1025154, rs4220 and rs1044291) were selected from the HapMap database on Han Chinese. Genotypes were determined in 1,294 unrelated subjects from the Hong Kong Cardiovascular Risk Factor Prevalence Study cohort. There were 199 hypertensive subjects at baseline. Among 1,095 subjects normotensive at baseline, 178 developed hyper-tension during a median follow-up period of 6.4 years. Among the three tagging SNPs, rs4220 showed significant association with hypertension at both baseline (odds ratio [OR]=1.49, p=0.004) and at follow-up (OR=1.32, p=0.013). The minor A allele of this SNP was associated with higher plasma fibrinogen level (β=0.144, p<0.001 at baseline and β=0.130, p<0.001 at follow-up). Among subjects normotensive at baseline, this SNP was also associated with the development of hyper-tension in men (OR=1.52, p=0.022), but not in women. The SNP rs4220 in FGB, which leads to the substitution of arginine by lysine at position 448, is independently associated with plasma fibrinogen level and hypertension in Hong Kong Chinese. This suggests a possible causal role of fibrinogen in hypertension development, especially in men.

Keywords

Fibrinogen - hypertension - single nucleotide polymorphisms

• References

• 1 Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-963.
• 2 Imperatore G, Riccardi G, Iovine C. et al. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998; 21: 649-654.
• 3 Fibrinogen Studies Collaboration. Danesh J, Lewington S, Thompson SG. et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809.
• 4 Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393.
• 5 Kant JA, Fornace Jr AJ, Saxe D. et al. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci USA 1985; 82: 2344-2348.
• 6 Smith GD, Harbord R, Milton J. et al. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb Vasc Biol 2005; 25: 2228-2233.
• 7 Shankar A, Wang JJ, Rochtchina E. et al. Positive association between plasma fibrinogen level and incident hypertension among men: population-based cohort study. Hypertension 2006; 48: 1043-1049.
• 8 Kolz M, Baumert J, Gohlke H. et al. Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: results from the MONICA/KORA study. Thromb Haemost 2009; 101: 317-324.
• 9 Folsom AR, Peacock JM, Nieto FJ. et al. Plasma fibrinogen and incident hypertension in the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens 1998; 16: 1579-1583.
• 10 Cheng J, Zhao D, Wang W. et al. Association between plasma fibrinogen concentration and ten-year change in blood pressure. Zhonghua Yi Xue Za Zhi 2008; 88: 2263-2266 (in Chinese).
• 11 Wong LY, Ong KL, Cheung BM. et al. Polymorphisms of the fibrinogen-beta gene are related to 2-hour glucose level after oral glucose tolerance test in Hong Kong Chinese. Dis Markers 2008; 24: 167-173.
• 12 Cheung BM, Wat NM, Tso AW. et al. Association between raised blood pressure and dysglycemia in Hong Kong Chinese. Diabetes Care 2008; 31: 1889-1891.
• 13 Cheung BM, Wat NM, Man YB. et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007; 30: 1430-1436.
• 14 Cheung BM, Wat NM, Tam S. et al. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clin Endocrinol (Oxf) 2008; 68: 730-737.
• 15 Ong KL, Leung R, Wong LY. et al. Association of F11 receptor gene polymorphisms with central obesity and blood pressure. J Intern Med 2008; 263: 322-332.
• 16 The International HapMap Consortium.. The International HapMap Project. Nature 2003; 426: 789-796.
• 17 Barrett JC, Fry B, Maller J. et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
• 18 Purcell S, Neale B, Todd-Brown K. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
• 19 Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
• 20 Engström G, Janzon L, Berglund G. et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002; 22: 2054-2058.
• 21 Smith GD, Lawlor DA, Harbord R. et al. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2007; 04: e352.
• 22 Cheung BM, Li M, Ong KL. et al. High density lipoprotein-cholesterol levels increase with age in American women but not in Hong Kong Chinese women. Clin Endocrinol (Oxf) 2009; 70: 561-568.
• 23 Behague I, Poirier O, Nicaud V. et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l‘Infarctus du Myocarde. Circulation 1996; 93: 440-449.
• 24 Sie MP, Isaacs A, de Maat MP. et al. Genetic variation in the fibrinogen-alpha and fibrinogen-gamma genes in relation to arterial stiffness: the Rotterdam Study. J Hypertens 2009; 27: 1392-1398.
• 25 Cheung EY, Bos MJ, Leebeek FW. et al. Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study. Thromb Haemost 2008; 100: 308-313.
• 26 Scott EM, Ariëns RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
• 27 Carter AM, Catto AJ, Bamford JM. et al. Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 589-594.
• 28 Brown ET, Fuller GM. Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. Blood 1998; 92: 3286-3293.
• 29 Humphries SE, Cook M, Dubowitz M. et al. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 329: 1452-1455.
• 30 Ben Assayag E, Bova I, Berliner S. et al. Gender differences in the expression of erythrocyte aggregation in relation to B beta-fibrinogen gene polymorphisms in apparently healthy individuals. Thromb Haemost 2006; 95: 428-433.
• 31 Thomas A, Lamlum H, Humphries S. et al. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A-455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum Mutat 1994; 03: 79-81.
• 32 Lewington S, Clarke R, Qizilbash N. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
• 33 Chen X, Xu M, Jin L. et al. Association of beta-fibrinogen gene –148C/T and –455G/A polymorphisms and coronary artery disease in Chinese population: a meta analysis. Sci China C Life Sci 2008; 51: 814-20.
• 34 Hoppe B, Tolou F, Dörner T. et al. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost 2006; 96: 465-470.
• 35 Kain K, Blaxill JM, Catto AJ. et al. Increased fibrinogen levels among South Asians versus Whites in the United Kingdom are not explained by common polymorphisms. Am J Epidemiol 2002; 156: 174-179.
• 36 Carty CL, Cushman M, Jones D. et al. Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost 2008; 99: 388-395.
• 37 Keavney B, Danesh J, Parish S. et al. Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization‘. Int J Epidemiol 2006; 35: 935-943.
• 38 Chen XC, Xu MT, Zhou W. et al. A meta-analysis of beta-fibrinogen gene-455G/A polymorphism and plasma fibrinogen level in Chinese cerebral infarction patients. Biomed Environ Sci 2007; 20: 366-372.
• 39 Xu X, Li J, Sheng W. et al. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis 2008; 26: 48-62.
• 40 Lam KS, Ma OC, Wat NM. et al. Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes. Diabetologia 1999; 42: 1250-1253.